Skip to main content
David Cachia, MD, Neurology, Worcester, MA

David Cachia MD

Neurology•Worcester, MA

Neurophysiology, Neurooncology

Neuro oncologist at the University of Massachusetts

Join to View Full Profile

  • 55 Lake Ave NWorcester, MA 01655

  • Phone+1 508-334-3550

  • Fax+1 774-442-9130

Dr. Cachia is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Cachia's Full ProfileAlready have an account?

Summary

  • Dr. David Cachia is a neurologist based in Worcester, MA, specializing in neurophysiology and neuro-oncology. He completed his medical education at the University of Malta, followed by further training and fellowships at UMass Chan Medical School and the University of Texas MD Anderson Cancer Center. Dr. Cachia currently serves as Clinical Chief and Professor at the University of Massachusetts Medical School, and previously held a role as Assistant Professor at MUSC Health University Medical Center. His research includes work on neuro-oncology, gliomas, and neurological complications of cancer, with several of his publications contributing to these fields. Throughout his career, Dr. Cachia has received multiple recognitions, including the Alpha Omega Alpha Medical Honor Society membership and a Clinical Scholars Award from MUSC Cancer Center.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 2013 - 2015
  • UMass Chan Medical School
    UMass Chan Medical SchoolFellowship, Clinical Neurophysiology, 2012 - 2013
  • UMass Chan Medical School
    UMass Chan Medical SchoolResidency, Neurology, 2009 - 2012
  • UMass Chan Medical School
    UMass Chan Medical SchoolInternship, Internal Medicine, 2008 - 2009
  • University of Malta School of Medicine
    University of Malta School of MedicineClass of 2001

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2011 - 2027
  • SC State Medical License
    SC State Medical License 2015 - 2023
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017

Publications & Presentations

PubMed

Journal Articles

  • Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma  
    Mandel JJ, Yust-Katz S, Patel A, Cachia D, Liu D, Park M, Yuan Y, Kent K, de Groot JF, Neuro Oncol, 1/10/2018
  • Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients  
    Cachia D, Elshafeey NA, Kamiya-Matsuoka C, Hatami M, Alfaro-Munoz KD, Mandel JJ, Colen R, DeGroot JF, J Neurooncol, 1/1/2017
  • Dorsal Column Myelopathy after Intrathecal Chemotherapy for Leukemia  
    Pinnix CC, Chi L, Jabbour EJ, Milgrom SA, Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, Kamiya C, Woodman K, Dinardo C, Jain N, Kadia TM, Pemmaraju N, Oh..., Am J Hematol, 1/1/2017

Books/Book Chapters

  • 5 Minute Clinical Consult 
    Chapter: Cluster Headache 
    Cachia D, Mitchell A, Fontneau N2012
  • Merritt's Neurology 
    Chapter: Spinal Tumors 
    Cachia D, Tatsui C, Gilbert MREdition 13th,
  • Ependymomas: Prognostic Factors, Treatment Strategies and Clinical Outcomes 
    Chapter: Prognosis and outcomes in ependymal tumors. 
    Metrus NR, Cachia D

Abstracts/Posters

  • Overcoming Radiation Resistance in Meningioma: The Emerging Role of CDK4/6 Inhibitor.
    Cachia D, Society of Neuro-Oncology Meeting, New Orleans, LA, 1/1/2018
  • C18-Ceramide Analogue Drug Overcomes Resistance to Temozolomide in Gliobastoma.
    Cachia D, Society of Neuro-Oncology Meeting, New Orleans, LA, 1/1/2018
  • Galectin-1 upregulates CXCR4 in glioblastoma through upregulation of CXCR4 via NF-KappaB activation.
    Cachia D, American Association for Cancer Research, 1/1/2018

Lectures

  • Treatment of Diffuse Gliomas in Adults: What's New? 
    1/1/2018
  • Anti-Tumor Activity of CDK 4/6 Inhibitor Palbociclib in Rb+ Meningioma: Pre-clinical Assessment. 
    1/1/2016
  • RIP3 is a Critical Regulator of Radiation Induced Programmed Necrosis and Inflammation in a Preclinical Model of Glioblastoma. 
    1/1/2016

Press Mentions

  • MUSC Studying How COVID-19 Impacts Those with Cancer
    MUSC Studying How COVID-19 Impacts Those with CancerFebruary 25th, 2021
  • Study Seeks to Better Understand How COVID-19 and Cancer Intersect
    Study Seeks to Better Understand How COVID-19 and Cancer IntersectFebruary 8th, 2021
  • MUSC Using Virus to Fight Brain Cancer
    MUSC Using Virus to Fight Brain CancerOctober 11th, 2016

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. David Cachia, Dr. David Cachia, MD, Dr. D Cachia